| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cannabinoid receptor 2 |
|---|
| Ligand | BDBM50340314 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_741484 (CHEMBL1763799) |
|---|
| IC50 | 44±n/a nM |
|---|
| Citation |  Trotter, BW; Nanda, KK; Burgey, CS; Potteiger, CM; Deng, JZ; Green, AI; Hartnett, JC; Kett, NR; Wu, Z; Henze, DA; Della Penna, K; Desai, R; Leitl, MD; Lemaire, W; White, RB; Yeh, S; Urban, MO; Kane, SA; Hartman, GD; Bilodeau, MT Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy. Bioorg Med Chem Lett21:2354-8 (2011) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cannabinoid receptor 2 |
|---|
| Name: | Cannabinoid receptor 2 |
|---|
| Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 39690.94 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P34972 |
|---|
| Residue: | 360 |
|---|
| Sequence: | MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILS
SHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTAS
VGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCS
ELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLD
VRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYA
LRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
|
|
|
|---|
| BDBM50340314 |
|---|
| n/a |
|---|
| Name | BDBM50340314 |
|---|
| Synonyms: | 1-[(1,1-dioxidothiomorpholin-4-yl)methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]imidazo[1,5-a]pyridine-3-carboxamide | CHEMBL1760934 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H18F3N5O3S |
|---|
| Mol. Mass. | 453.438 |
|---|
| SMILES | FC(F)(F)c1cccc(NC(=O)c2nc(CN3CCS(=O)(=O)CC3)c3ccccn23)n1 |
|---|
| Structure | 
|
|---|
Search and Browse
